83690

Lipase

Current Procedural Terminology (CPT) code 83690 designates the laboratory quantitative analysis of the enzyme lipase, typically performed on a blood serum or plasma specimen. Lipase is an essential digestive enzyme synthesized and secreted primarily by the acinar cells of the pancreas. Its primary physiological function is the hydrolysis of dietary triglycerides into free fatty acids and glycerol, facilitating their absorption in the gastrointestinal tract. Under normal physiological conditions, only trace amounts of lipase are present in the systemic circulation. However, when the pancreatic parenchyma experiences inflammation, trauma, or ductal obstruction, lipase is released directly into the bloodstream in significant quantities, resulting in marked hyperlipasemia. The 83690 assay is the cornerstone biochemical diagnostic tool for acute pancreatitis. In the clinical setting, an elevation of serum lipase to at least three times the upper limit of the normal reference range is highly specific and sensitive for the diagnosis of acute pancreatitis, particularly when coupled with characteristic epigastric pain that radiates to the back. Unlike amylase, another pancreatic enzyme frequently measured in the past, lipase remains elevated in the bloodstream for a longer duration (up to eight to fourteen days) following an acute inflammatory event, thereby providing a wider diagnostic window. Furthermore, lipase exhibits superior specificity to the pancreas, whereas amylase can originate from the salivary glands and other non-pancreatic sources. Beyond acute pancreatitis, CPT code 83690 is utilized to investigate a variety of other hepatobiliary and gastrointestinal pathologies. These include chronic pancreatitis, pancreatic pseudocysts, exocrine pancreatic insufficiency, pancreatic malignancies, biliary tract disease such as choledocholithiasis and cholecystitis, peptic ulcer disease with posterior perforation into the pancreas, and even certain presentations of celiac disease. The laboratory procedure typically employs an automated chemistry analyzer utilizing enzymatic, colorimetric, or turbidimetric methodologies. A specific substrate, such as a synthetic ester or an emulsion of triglycerides, is added to the patient's serum. The rate of substrate cleavage or the subsequent change in light absorbance is directly proportional to the lipase activity within the sample. The results provide critical, actionable clinical intelligence for the treating physician, guiding both initial management, such as intravenous fluid resuscitation, pain control, and fasting protocols, and subsequent therapeutic interventions for patients presenting with severe abdominal pathology.

Clinical Indications

  • Evaluation of suspected acute pancreatitis
  • Monitoring of chronic pancreatitis exacerbations
  • Assessment of severe epigastric or unexplained abdominal pain
  • Diagnosis of pancreatic pseudocysts or abscesses
  • Evaluation of biliary tract obstruction or severe cholecystitis
  • Investigation of exocrine pancreatic insufficiency
  • Monitoring of patients receiving medications known to induce drug-induced pancreatitis

Procedure Steps

  1. Venipuncture is performed to collect a whole blood sample into an appropriate collection tube, typically a serum separator tube or plasma tube.
  2. The blood sample is transported to the laboratory and centrifuged to separate the serum or plasma from the cellular components.
  3. The processed serum or plasma sample is loaded into an automated clinical chemistry analyzer.
  4. A specific reagent containing a lipid substrate and co-lipase is introduced to the patient's sample by the analyzer.
  5. The analyzer measures the enzymatic cleavage of the substrate utilizing colorimetric, turbidimetric, or fluorometric methodologies.
  6. The analyzer calculates the quantitative lipase activity concentration based on the measured rate of the chemical reaction.
  7. Quality control parameters and assay calibrations are verified by the laboratory technologist.
  8. The final quantitative lipase level is generated and electronically transmitted to the ordering clinician's electronic health record system.

Coding Guidelines

  • Report CPT 83690 for each distinct quantitative laboratory measurement of lipase.
  • Do not report 83690 in conjunction with comprehensive panels if the specific laboratory panel definition already includes a lipase measurement, unless medically necessary as a distinct, subsequent test.
  • If multiple lipase tests are clinically necessary on the exact same date of service (e.g., serial monitoring for a critically ill patient), append modifier 91 to the second and subsequent tests.
  • Routine venipuncture (e.g., CPT 36415) is typically reported separately when performed by the same provider or facility, subject to payer policies.
  • Ensure the reported ICD-10-CM diagnosis code accurately reflects the medical necessity for the test, such as acute abdominal pain, a known pancreatic disorder, or a related biliary condition.

Associated ICD-10 Codes